M&T Bank Corp lowered its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 2.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,149 shares of the medical instruments supplier’s stock after selling 1,205 shares during the period. M&T Bank Corp’s holdings in DENTSPLY SIRONA were worth $2,928,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the business. California Public Employees Retirement System raised its position in DENTSPLY SIRONA by 2.1% in the 2nd quarter. California Public Employees Retirement System now owns 488,698 shares of the medical instruments supplier’s stock valued at $31,687,000 after purchasing an additional 10,100 shares in the last quarter. FIL Ltd raised its position in DENTSPLY SIRONA by 33.3% in the 2nd quarter. FIL Ltd now owns 934,760 shares of the medical instruments supplier’s stock valued at $60,611,000 after purchasing an additional 233,760 shares in the last quarter. MML Investors Services LLC acquired a new stake in DENTSPLY SIRONA in the 2nd quarter valued at about $210,000. Vanguard Group Inc. raised its position in DENTSPLY SIRONA by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 22,728,062 shares of the medical instruments supplier’s stock valued at $1,473,688,000 after purchasing an additional 562,993 shares in the last quarter. Finally, Citigroup Inc. raised its position in DENTSPLY SIRONA by 73.1% in the 2nd quarter. Citigroup Inc. now owns 85,543 shares of the medical instruments supplier’s stock valued at $5,546,000 after purchasing an additional 36,132 shares in the last quarter. 93.87% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “M&T Bank Corp Has $2.93 Million Holdings in DENTSPLY SIRONA Inc. (XRAY)” was first reported by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://www.watchlistnews.com/mt-bank-corp-has-2-93-million-holdings-in-dentsply-sirona-inc-xray/1588992.html.

XRAY has been the topic of a number of analyst reports. Stifel Nicolaus reaffirmed a “buy” rating and issued a $66.00 price target (down previously from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a research report on Thursday, July 13th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a research report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target on the stock. BidaskClub raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, June 30th. Finally, Jefferies Group LLC reduced their price target on DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating on the stock in a research report on Wednesday, August 23rd. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the stock. DENTSPLY SIRONA presently has an average rating of “Hold” and an average price target of $65.80.

Shares of DENTSPLY SIRONA Inc. (XRAY) opened at 59.16 on Tuesday. The stock’s 50 day moving average price is $56.98 and its 200 day moving average price is $61.67. DENTSPLY SIRONA Inc. has a 12 month low of $52.54 and a 12 month high of $65.68. The firm’s market cap is $13.58 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, meeting analysts’ consensus estimates of $0.65. The firm had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. DENTSPLY SIRONA’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.76 earnings per share. Equities research analysts predict that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be issued a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -10.09%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.